Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review

Background: It has been suggested that a relevant proportion of patients do not respond to nonselective beta-blockers (NSBB)s, which raises questions regarding the need for individualized therapy. The existence of potential heterogeneity in the treatment response can be assessed using the variabilit...

Descripción completa

Detalles Bibliográficos
Autores: Alsaeid, Mohammad, Sung, Shuen, Bai, Wayne, Tam, Matthew, Wong, Yu Jun, Cortés Martínez, Jordi|||0000-0002-3764-0795, Cobo Valeri, Erik|||0000-0002-3534-5602, González Alastrué, José Antonio|||0000-0002-3113-4779, González Abraldes, Juan
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/400928
Acceso en línea:https://hdl.handle.net/2117/400928
https://dx.doi.org/10.1097/HC9.0000000000000321
Access Level:acceso abierto
Palabra clave:Medical statistics
Estadística mèdica
Classificació AMS::62 Statistics::62H Multivariate analysis
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària
id ES_7edd5ec9a08171bebe5fc1dce0d97c1c
oai_identifier_str oai:upcommons.upc.edu:2117/400928
network_acronym_str ES
network_name_str España
repository_id_str
spelling Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic reviewAlsaeid, MohammadSung, ShuenBai, WayneTam, MatthewWong, Yu JunCortés Martínez, Jordi|||0000-0002-3764-0795Cobo Valeri, Erik|||0000-0002-3534-5602González Alastrué, José Antonio|||0000-0002-3113-4779González Abraldes, JuanMedical statisticsEstadística mèdicaClassificació AMS::62 Statistics::62H Multivariate analysisÀrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitàriaBackground: It has been suggested that a relevant proportion of patients do not respond to nonselective beta-blockers (NSBB)s, which raises questions regarding the need for individualized therapy. The existence of potential heterogeneity in the treatment response can be assessed using the variability ratio (VR) of the outcome measurement (in this case, HVPG) between the treated and placebo groups. We conducted a systematic review and meta-analysis of randomized controlled trials to assess the potential heterogeneity in the portal pressure response to NSBBs. Methods: After a systematic search, we quantified the heterogeneity of treatment response with the VR between the treatment and control groups, with VR > 1 indicating potential heterogeneity. We used a similar approach to compare carvedilol with propranolol and statins with placebo. Results: We identified 18 studies that included 965 patients. A comparison between beta-blockers and placebo showed a pooled VR of 0.99 (95% CI:0.87–1.14), which suggests a homogeneous HVPG response to NSBB at the individual patient level (ie, no evidence to support that some patients responded to beta-blockers and others did not). For the comparison between carvedilol and propranolol, pooled VR was 0.97 (95% CI 0.82–1.14), suggesting that carvedilol achieves a greater average response (rather than an increase in the proportion of responders). There was no evidence of a heterogeneous response to statins. Conclusion: Our analysis did not support the existence of a heterogeneous patient-by-patient response to NSBBs in cirrhosis. These findings challenge the concept of personalized therapy based on portal pressure response and indicate that routine portal pressure measurement may not be necessary to guide NSBB therapy.The authors JC and EC acknowledge the support of the Ministerio de Ciencia e Innovación (Spain) [PID2019- 104830RB-I00/ DOI (AEI): 10.13039/501100011033] and the Generalitat de Catalunya (Spain) (2021SGR01421).Peer Reviewed20242024-02-0120242024-02-05journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/2117/400928https://dx.doi.org/10.1097/HC9.0000000000000321reponame:UPCommons. Portal del coneixement obert de la UPCinstname:Universitat Politècnica de Catalunya (UPC)InglésengAgencia Estatal de Investigación http://doi.org/10.13039/501100011033 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104830RB-I00 METODOLOGIAS ESTADISTICAS PARA DATOS CLINICOS Y OMICOS Y SUS APLICACIONES EN CIENCIAS DE LA SALUDopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:upcommons.upc.edu:2117/4009282026-05-27T15:37:01Z
dc.title.none.fl_str_mv Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
title Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
spellingShingle Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
Alsaeid, Mohammad
Medical statistics
Estadística mèdica
Classificació AMS::62 Statistics::62H Multivariate analysis
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària
title_short Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
title_full Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
title_fullStr Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
title_full_unstemmed Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
title_sort Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: a systematic review
dc.creator.none.fl_str_mv Alsaeid, Mohammad
Sung, Shuen
Bai, Wayne
Tam, Matthew
Wong, Yu Jun
Cortés Martínez, Jordi|||0000-0002-3764-0795
Cobo Valeri, Erik|||0000-0002-3534-5602
González Alastrué, José Antonio|||0000-0002-3113-4779
González Abraldes, Juan
author Alsaeid, Mohammad
author_facet Alsaeid, Mohammad
Sung, Shuen
Bai, Wayne
Tam, Matthew
Wong, Yu Jun
Cortés Martínez, Jordi|||0000-0002-3764-0795
Cobo Valeri, Erik|||0000-0002-3534-5602
González Alastrué, José Antonio|||0000-0002-3113-4779
González Abraldes, Juan
author_role author
author2 Sung, Shuen
Bai, Wayne
Tam, Matthew
Wong, Yu Jun
Cortés Martínez, Jordi|||0000-0002-3764-0795
Cobo Valeri, Erik|||0000-0002-3534-5602
González Alastrué, José Antonio|||0000-0002-3113-4779
González Abraldes, Juan
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Medical statistics
Estadística mèdica
Classificació AMS::62 Statistics::62H Multivariate analysis
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària
topic Medical statistics
Estadística mèdica
Classificació AMS::62 Statistics::62H Multivariate analysis
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària
description Background: It has been suggested that a relevant proportion of patients do not respond to nonselective beta-blockers (NSBB)s, which raises questions regarding the need for individualized therapy. The existence of potential heterogeneity in the treatment response can be assessed using the variability ratio (VR) of the outcome measurement (in this case, HVPG) between the treated and placebo groups. We conducted a systematic review and meta-analysis of randomized controlled trials to assess the potential heterogeneity in the portal pressure response to NSBBs. Methods: After a systematic search, we quantified the heterogeneity of treatment response with the VR between the treatment and control groups, with VR > 1 indicating potential heterogeneity. We used a similar approach to compare carvedilol with propranolol and statins with placebo. Results: We identified 18 studies that included 965 patients. A comparison between beta-blockers and placebo showed a pooled VR of 0.99 (95% CI:0.87–1.14), which suggests a homogeneous HVPG response to NSBB at the individual patient level (ie, no evidence to support that some patients responded to beta-blockers and others did not). For the comparison between carvedilol and propranolol, pooled VR was 0.97 (95% CI 0.82–1.14), suggesting that carvedilol achieves a greater average response (rather than an increase in the proportion of responders). There was no evidence of a heterogeneous response to statins. Conclusion: Our analysis did not support the existence of a heterogeneous patient-by-patient response to NSBBs in cirrhosis. These findings challenge the concept of personalized therapy based on portal pressure response and indicate that routine portal pressure measurement may not be necessary to guide NSBB therapy.
publishDate 2024
dc.date.none.fl_str_mv 2024
2024-02-01
2024
2024-02-05
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/2117/400928
https://dx.doi.org/10.1097/HC9.0000000000000321
url https://hdl.handle.net/2117/400928
https://dx.doi.org/10.1097/HC9.0000000000000321
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Agencia Estatal de Investigación http://doi.org/10.13039/501100011033 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104830RB-I00 METODOLOGIAS ESTADISTICAS PARA DATOS CLINICOS Y OMICOS Y SUS APLICACIONES EN CIENCIAS DE LA SALUD
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:UPCommons. Portal del coneixement obert de la UPC
instname:Universitat Politècnica de Catalunya (UPC)
instname_str Universitat Politècnica de Catalunya (UPC)
reponame_str UPCommons. Portal del coneixement obert de la UPC
collection UPCommons. Portal del coneixement obert de la UPC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411781467701248
score 15,300719